Skip to main content
SpringerLink
Log in

Antioxidative effects of statins

  • Review Article
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Abstract HMG CoA reductase inhibitiors (statins) have been shown to be effective lipid lowering agents and are beneficial in the primary and secondary prevention of coronary heart disease. However, the overall benefits observed with statins appear to be greater than what might be expected from changes in lipid levels alone and the positive effects have only partially been reproduced with other lipid lowering drugs, suggesting effects in addition to cholesterol lowering. In experimental models, many of the cholesterol-independent effects of statins are mediated by inhibition of isoprenoids, which serve as lipid attachments for intracellular signalling molecules such as small Rho guanosine triphosphate-binding proteins, whose membrane localization and function are dependent on isoprenylation. This review summarizes the effects of statins on endothelial function and oxidative stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Adam O, Frost G, Custodis F, Sussman MA, Schafers HJ, Bohm M, Laufs U (2007) Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 50:359–367

    Article  PubMed  CAS  Google Scholar 

  • Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Zhu W, Kadowaki T, Yazaki Y (1999) Rho family small G proteins play critical roles in mechanical stress- induced hypertrophic responses in cardiac myocytes. Circ Res 84:458–466

    PubMed  CAS  Google Scholar 

  • Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, Nagai R, Komuro I (2000) Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102:2873–2879

    PubMed  CAS  Google Scholar 

  • Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Moskowitz MA (2001) Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32:980–986

    PubMed  CAS  Google Scholar 

  • Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P (1995) The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332:488–493

    Article  PubMed  CAS  Google Scholar 

  • Andreoli TE (2000) Free radicals and oxidative stress. Am J Med 108:650–651

    Article  PubMed  CAS  Google Scholar 

  • Bendall JK, Cave AC, Heymes C, Gall N, Shah AM (2002) Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105:293–296

    Article  PubMed  CAS  Google Scholar 

  • Blum CB (1994) Comparison of properties of four inhibitors of 3-hydroxy-3- methylglutaryl-coenzyme A reductase. Am J Cardiol 73:3D–11D

    Article  PubMed  CAS  Google Scholar 

  • Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844

    PubMed  CAS  Google Scholar 

  • Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, Wilcox JN, Dudley SC Jr, Harrison DG, Langberg JJ (2002) Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106:2764–2766

    Article  Google Scholar 

  • Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S, Kanderian A, Pavia S, Hamlin RL, McCarthy PM, Bauer JA, Van Wagoner DR (2001) Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89:E32–E38

    Article  PubMed  CAS  Google Scholar 

  • Corsini A, Maggi FM, Catapano AL (1995) Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res 31:9–27

    Article  PubMed  CAS  Google Scholar 

  • Custodis F, Eberl M, Kilter H, Böhm M, Laufs U (2006) Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res 71:342–351

    Article  PubMed  CAS  Google Scholar 

  • Dixon LJ, Morgan DR, Hughes SM, McGrath LT, El Sherbeeny NA, Plumb RD, Devine A, Leahey W, Johnston GD, McVeigh GE (2003) Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure. Circulation 107:1725–1728

    Article  PubMed  CAS  Google Scholar 

  • Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, Fukai T, Harrison DG, Dikalov SI, Langberg J (2005) Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112:1266–1273

    Article  PubMed  CAS  Google Scholar 

  • Endres M, Laufs U (2006) Discontinuation of statin treatment in stroke patients. Stroke 37:2640–2643

    Article  PubMed  CAS  Google Scholar 

  • Endres M, Laufs U (2008) The medical case for the development of an intravenous statin formulation—beyond ischemic stroke. Cerebrovasc Dis 25:593–594

    Article  PubMed  Google Scholar 

  • Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880–8885

    Article  PubMed  CAS  Google Scholar 

  • Feron O, Dessy C, Desager JP, Balligand JL (2001) Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103:113–118

    PubMed  CAS  Google Scholar 

  • Finkel T (1999) Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 65:337–340

    PubMed  CAS  Google Scholar 

  • Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597–601

    Article  PubMed  CAS  Google Scholar 

  • Gao WD, Liu Y, Marban E (1996) Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle. Implications for the mechanism of stunned myocardium. Circulation 94:2597–2604

    PubMed  CAS  Google Scholar 

  • Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000. A historical look to the future. Ann NY Acad Sci 899:136–147

    Article  PubMed  CAS  Google Scholar 

  • Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279:509–514

    Article  PubMed  CAS  Google Scholar 

  • Harrison DG (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100:2153–2157

    Article  PubMed  CAS  Google Scholar 

  • Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, Lamas S (1998) Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101:2711–2719

    Article  PubMed  CAS  Google Scholar 

  • Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, Shah AM (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41:2164–2171

    Article  PubMed  CAS  Google Scholar 

  • Istvan ES, Deisenhofer J (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292:1160–1164

    Article  PubMed  CAS  Google Scholar 

  • John S, Delles C, Jacobi J, Schlaich MP, Schneider M, Schmitz G, Schmieder RE (2001) Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. J Am Coll Cardiol 37:1351–1358

    Article  PubMed  CAS  Google Scholar 

  • Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW (1999) Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol 33:234–241

    Article  PubMed  CAS  Google Scholar 

  • Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B (2005) A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97:629–636

    Article  PubMed  CAS  Google Scholar 

  • Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K (2000) The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6:1004–1010

    Article  PubMed  CAS  Google Scholar 

  • Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, Mueller M, Fuchs M, Hornig B, Haller H, Drexler H (2004) Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110:1933–1939

    Article  PubMed  CAS  Google Scholar 

  • Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK (2001) Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888–894

    Article  PubMed  CAS  Google Scholar 

  • Laufs U (2003) Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 58:719–731

    PubMed  CAS  Google Scholar 

  • Laufs U, Liao JK (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273:24266–24271

    Article  PubMed  CAS  Google Scholar 

  • Laufs U, La Fata L, Liao JK (1997) Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272:31725–31729

    Article  PubMed  CAS  Google Scholar 

  • Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129–1135

    PubMed  CAS  Google Scholar 

  • Laufs U, Marra D, Node K, Liao JK (1999) 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down- regulation of p27(Kip1). J Biol Chem 274:21926–21931

    Article  PubMed  CAS  Google Scholar 

  • Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Böhm M, Schoen FJ, Moskowitz MA, Liao JK (2000) Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 106:15–24

    Article  PubMed  CAS  Google Scholar 

  • Laufs U, Wassmann S, Hilgers S, Ribaudo N, Böhm M, Nickenig G (2001) Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 88:1306–1307

    Article  PubMed  CAS  Google Scholar 

  • Laufs U, Kilter H, Konkol C, Wassmann S, Böhm M, Nickenig G (2002) Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc Res 53:911–920

    Article  PubMed  CAS  Google Scholar 

  • Lea AP, McTavish D (1997) Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs 53:828–847

    Article  PubMed  CAS  Google Scholar 

  • Lee TM, Chou TF, Tsai CH (2002) Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation. J Cardiovasc Pharmacol 40:868–874

    Article  PubMed  CAS  Google Scholar 

  • Li JM, Shah AM (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287:R1014–R1030

    PubMed  CAS  Google Scholar 

  • Li JM, Gall NP, Grieve DJ, Chen M, Shah AM (2002) Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40:477–484

    Article  PubMed  CAS  Google Scholar 

  • Liao JK (1994) Inhibition of Gi proteins by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. J Biol Chem 269:12987–12992

    PubMed  CAS  Google Scholar 

  • Liao JK (1998) Endothelium and acute coronary syndromes. Clin Chem 44:1799–1808

    PubMed  CAS  Google Scholar 

  • Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89–118

    Article  PubMed  CAS  Google Scholar 

  • Liao JK, Bettmann MA, Sandor T, Tucker JI, Coleman SM, Creager MA (1991) Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res 68:1027–1034

    PubMed  CAS  Google Scholar 

  • Liao JK, Zulueta JJ, Yu FS, Peng HB, Cote CG, Hassoun PM (1995) Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest 96:2661–2666

    Article  PubMed  CAS  Google Scholar 

  • Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation 91:2844–2850

    PubMed  CAS  Google Scholar 

  • Maack C, Kartes T, Kilter H, Schäfers HJ, Nickenig G, Böhm M, Laufs U (2003) Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 108:1567–1574

    Article  PubMed  CAS  Google Scholar 

  • MacCarthy PA, Grieve DJ, Li JM, Dunster C, Kelly FJ, Shah AM (2001) Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation 104:2967–2974

    Article  PubMed  CAS  Google Scholar 

  • McTaggart F, Buckett L, Davidson R, Holdgate G, McCormick A, Schneck D, Smith G, Warwick M (2001) Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol 87:28B–32B

    Article  PubMed  CAS  Google Scholar 

  • Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA (2001) Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104:174–180

    PubMed  CAS  Google Scholar 

  • Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG (1995) Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95:187–194

    Article  PubMed  CAS  Google Scholar 

  • Nattel S, Khairy P, Roy D, Thibault B, Guerra P, Talajic M, Dubuc M (2002) New approaches to atrial fibrillation management: a critical review of a rapidly evolving field. Drugs 62:2377–2397

    Article  PubMed  Google Scholar 

  • O’Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95:1126–1131

    PubMed  CAS  Google Scholar 

  • Rikitake Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, Nishi H, Inoue N, Yokoyama M (2001) Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 154:87–96

    Article  PubMed  CAS  Google Scholar 

  • Rodwell VW, Nordstrom JL, Mitschelen JJ (1976) Regulation of HMG-CoA reductase. Adv Lipid Res 14:1–74

    PubMed  CAS  Google Scholar 

  • Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, Bohm M, Nickenig G (2003) Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93:170–177

    Article  PubMed  CAS  Google Scholar 

  • Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M, Liao JK (2001) Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108:1429–1437

    PubMed  CAS  Google Scholar 

  • Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T (1997) Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95:76–82

    PubMed  CAS  Google Scholar 

  • Tannous M, Cheung R, Vignini A, Mutus B (1999) Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects. Thromb Haemost 82:1390–1394

    PubMed  CAS  Google Scholar 

  • Tapon N, Hall A (1997) Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 9:86–92

    Article  PubMed  CAS  Google Scholar 

  • Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW (1995) Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332:481–487

    Article  PubMed  CAS  Google Scholar 

  • Tsunekawa T, Hayashi T, Kano H, Sumi D, Matsui-Hirai H, Thakur NK, Egashira K, Iguchi A (2001) Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 104:376–379

    Article  PubMed  CAS  Google Scholar 

  • Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK (1996) p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317–23321

    Article  PubMed  CAS  Google Scholar 

  • Van AL, D’Souza-Schorey C (1997) Rho GTPases and signaling networks. Genes Dev 11:2295–2322

    Article  Google Scholar 

  • Vega GL, Grundy SM (1998) Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men. Am J Cardiol 81:36B–42B

    Article  PubMed  CAS  Google Scholar 

  • Verhaar MC, Westerweel PE, van Zonneveld AJ, Rabelink TJ (2004) Free radical production by dysfunctional eNOS. Heart 90:494–495

    Article  PubMed  CAS  Google Scholar 

  • Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M (2000) Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20:61–69

    PubMed  CAS  Google Scholar 

  • Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, Itter G, Rösen R, Böhm M, Nickenig G (2001a) HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37:1450–1457

    PubMed  CAS  Google Scholar 

  • Wassmann S, Laufs U, Bäumer AT, Müller K, Konkol C, Sauer H, Böhm M, Nickenig G (2001b) Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 59:646–654

    PubMed  CAS  Google Scholar 

  • Wassmann S, Faul A, Hennen B, Scheller B, Böhm M, Nickenig G (2003) Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ Res 93:e98–e103

    Article  PubMed  CAS  Google Scholar 

  • Williams JK, Sukhova GK, Herrington DM, Libby P (1998) Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 31:684–691

    Article  PubMed  CAS  Google Scholar 

  • Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, Sawyer DB (2002) Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol Cell Physiol 282:C926–C934

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, 66421, Homburg, Saar, Germany

    Oliver Adam & Ulrich Laufs

Authors
  1. Oliver Adam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich Laufs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oliver Adam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adam, O., Laufs, U. Antioxidative effects of statins. Arch Toxicol 82, 885–892 (2008). https://doi.org/10.1007/s00204-008-0344-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-008-0344-4

Keywords

Search

Navigation